dexverapamil has been researched along with lekoptin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pajeva, IK; Wiese, M | 1 |
Choi, SU; Kwon, MJ; Lee, BH; Lee, CO; Yi, KY; Yoo, SE | 1 |
Dansette, PM; Fontana, E; Poli, SM | 1 |
Baubichon-Cortay, H; Chang, XB; Di Pietro, A; Perrotton, T; Trompier, D | 1 |
Avdeef, A; Tam, KY | 1 |
Chen, G; Hu, N; Liu, H; Liu, L; Liu, X; Pan, X; Wang, G; Wang, X; Xie, L; Xie, S; Zhang, L | 1 |
1 review(s) available for dexverapamil and lekoptin
Article | Year |
---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
5 other study(ies) available for dexverapamil and lekoptin
Article | Year |
---|---|
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).
Topics: Adenosine Triphosphatases; Algorithms; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Binding, Competitive; Caco-2 Cells; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Radioligand Assay; Rhodamine 123; Stereoisomerism; Verapamil; Vinblastine | 2002 |
Differential effects of the optical isomers of KR30031 on cardiotoxicity and on multidrug resistance reversal activity.
Topics: Animals; Antineoplastic Agents; Aorta; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Pressure; Calcium Channel Blockers; Colorectal Neoplasms; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Isomerism; Male; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured; Uterine Neoplasms; Vasodilation; Ventricular Function, Left; Verapamil | 2003 |
(R)- and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1.
Topics: Adenosine Triphosphatases; Animals; Cell Line; Cell Proliferation; Cell Survival; Cricetinae; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Fluoresceins; Fluorescent Dyes; Formazans; Glutathione; Inhibitory Concentration 50; Kidney; Leukotriene C4; Multidrug Resistance-Associated Proteins; Protein Conformation; Sodium Iodide; Spectrometry, Fluorescence; Stereoisomerism; Tetrazolium Salts; Transfection; Tryptophan; Verapamil | 2007 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Biological Availability; Calcium Channel Blockers; Cytochrome P-450 CYP3A; Diabetes Mellitus, Experimental; Half-Life; Injections, Intravenous; Intestine, Small; Male; Membrane Proteins; Metabolic Clearance Rate; Microsomes; Microsomes, Liver; Organ Specificity; Rats; Rats, Sprague-Dawley; Streptozocin; Verapamil | 2011 |